Comparative Volumetric Assessment of Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials
Tooth Fractures, Tooth Injuries, Tooth Diseases
About this trial
This is an interventional treatment trial for Tooth Fractures
Eligibility Criteria
Inclusion Criteria:
- Provision of informed consent
- ≥ 18 years and ≤ 75 years
- Good physical health (ASAI/II)
- Extraction of maxillary premolar, canine or incisor, or mandibular premolar and canine required
- Teeth adjacent (mesial and distal) to study site must consist of two stable natural teeth with minimal restorations, without signs of periodontal bone loss (> 3 mm) and/or significant soft tissue deficiencies
Exclusion Criteria:
- Buccal plate dehiscence and/or fenestration >3mm at study site following extraction
- Untreated rampant caries and uncontrolled periodontal disease
- Inadequate oral hygiene (estimated plaque score >20%)
- Smokers using more than 10 cigarettes or equivalent per day
- Smokeless tobacco use or e-cigarette use
Compromised physical health and/or uncontrolled or severe systemic diseases including:
ASA III/IV Metabolic bone disease History of malignancy History or radiotherapy or chemotherapy for malignancy in the past 5 years History of autoimmune disease Long-term steroidal or antibiotic therapy Uncontrolled diabetes Known alcohol or drug abuse
- Systemic or local disease or condition that would compromise post-operative healing
- Use of any substance or medication that will influence bone metabolism
- Known pregnancy
- Unable or unwilling to return for follow-up visits for a period of 6 months
- Unlikely to be able to comply with study procedures according to Investigators judgement
- Involvement in the planning and conduct of the study
- Previous enrollment or randomization of treatment in the present study
Sites / Locations
- University of North Carolina School of Dentistry
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Group A- Allograft, Membrane
Group B- Alloplast, Membrane
Group C- Xenograft, Membrane
Group D- Membrane
Symbios mineralized cortical-cancellous granule mix, Symbios OsteoShield Collagen Resorbable Membrane
Symbios OsteoGraf/LD-300, Symbios OsteoShield Collagen Resorbable Membrane
OsteoGraf/N-300 , Symbios OsteoShield Collagen Resorbable Membrane
Symbios OsteoShield Collagen Resorbable Membrane